The measurement of nocturia and its impact on quality of sleep and quality of life in LUTS/BPH

European Urology, Supplements

Volumn 5, Issue 1, 2006, Pages 3-11

  Chartier Kastler, Emmanuel ^a   Tubaro, Andrea ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Benign prostatic hyperplasia; Hours of undisturbed sleep; Lower urinary tract symptoms; Methodology; Nocturia; Quality of life; Questionnaire; Sleep

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LONG TERM CARE; MORBIDITY; MORTALITY; NOCTURIA; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SLEEP; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; TRANSURETHRAL RESECTION; URINARY TRACT DISEASE;

EID: 29344442825     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2005.10.003     Document Type: Conference Paper

References (58)

1. M.J. Speakman Initial choices and final outcomes in lower urinary tract symptoms Eur Urol 40 Suppl 4 2001 21 30
2. O.W. Hakenberg, C.B. Pinnock, and V.R. Marshall The follow-up of patients with unfavourable early results of transurethral prostatectomy BJU Int 84 1999 799 804
3. O. Ichiyanagi, M. Ishigooka, T. Hashimoto, S. Hayani, Y. Suzuki, and T. Nakada The American Urological Association Symptom Index: early post-operative evaluation of irritative and obstructive symptoms due to benign prostatic hyperplasia Int Urol Nephrol 29 1997 441 447
4. I. Ignjatovic Symptoms and urodynamics after unsuccessful transurethral prostatectomy Int Urol Nephrol 32 2001 655 658
5. T.J. Peters, J.L. Donovan, H.E. Kay, P. Abrams, J.J.M.C.H. de la Rosette, and D. Porru The International Continence Society 'Benign Prostatic Hyperplasia' Study: the bothersomeness of urinary symptoms J Urol 157 1997 885 889
6. P. Abrams, L. Cardozo, M. Fall, D. Griffiths, P. Rosier, and U. Ulmsten The standardization of terminology in lower urinary tract function: report from the standardization subcommittee of the International Continence Society Urology 61 2003 37 49
7. P. Van Kerrebroeck, P. Abrams, D. Chaikin, J. Donovan, D. Fonda, and S. Jackson The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society BJU Int 90 Suppl 3 2002 11 15
8. R. Asplund Nocturia: consequences for sleep and daytime activities and associated risks Eur Urol Suppl 3 6 2005 24 32
9. D. Mitropoulos, I. Anastasiou, C. Giannopoulou, P. Nikolopoulos, C. Alamanis, and A. Zervas Symptomatic benign prostatic hyperplasia: impact on partners' quality of life Eur Urol 41 2002 240 245
10. H.A.M. Middelkoop, D.A. Smilde van den Doel, A.K. Neven, H.A.C. Kamphuisen, and C.P Springer Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep J Gerontol A 51 1996 M108 M115
11. R. Asplund, and H. Åberg Health of the elderly with regard to sleep and nocturnal micturition Scand J Prim Health Care 10 1992 98 104
12. P. Abrams Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO) Eur Urol Suppl 3 6 2005 8 16
13. M. Thomas, H. Sing, G. Belenky, H. Holcomb, H. Mayberg, and R. Dannals Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity J Sleep Res 9 2000 335 352
14. G. Kobelt, F. Borgström, and A. Mattiasson Productivity, vitality and utility in a group of healthy profesionnally active individuals with nocturia BJU Int 91 2003 190 195
15. R. Asplund Nocturia in relation to sleep, somatic disease and medical treatment in the elderly BJU Int 90 2002 302 313
16. M.A. Carskadon Sleep deprivation: health consequences and societal impact Med Clin N Am 88 2004 767 776
17. T. Åkerstedt, A. Knutsson, P. Westerholm, T. Theorell, L. Alfredsson, and G. Kecklund Work organization and unintentional sleep: results from the WOLF study Occup Environ Med 59 2002 595 600
18. I. Radun, and H. Summala Sleep-related fatal vehicle accidents: characteristics of decisions made by multidisciplinary investigation teams Sleep 27 2004 224 227
19. A.W. MacLean, D.R. Davies, and K. Thiele The hazards and prevention of driving while sleepy Sleep Med Rev 7 2003 507 521
20. R. Asplund, S. Henriksson, S. Johansson, and G. Isacsson Nocturia and depression BJU Int 93 2004 1253 1256
21. R. Asplund Mortality in the elderly in relation to nocturnal micturition BJU Int 84 1999 297 301
22. R. Asplund Sleep and cardiac diseases amongst elderly people J Intern Med 236 1994 65 71
23. N. Kawakami, N. Takatsuka, and H. Shimizu Sleep disturbance and onset of Type-2 diabetes Diabetes Care 27 2004 282 283
24. T.M. Johnson, K. Jones, W.O. Williford, M.H. Kutner, M.M. Issa, and H. Lepor Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial J Urol 170 2003 145 148
25. N. Zinner, and C. Roehrborn Dutasteride treatment improves nocturia in men with symptomatic benign prostatic hyperplasia Prog Urol 15 Suppl. 2 2005 26 (abs. 80)
26. Y. Homma, T. Yamaguchi, Y. Kondo, S. Horie, S. Takahashi, and T. Kitamura Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia J Urol 167 2002 172 176
27. K. Yoshimura, H. Ohara, K. Ichioka, N. Terada, Y. Matsui, and A. Terai Nocturia and benign prostatic hyperplasia Urology 61 2003 786 790
28. 1c-adrenoceptor antagonist: a randomised, controlled trial in patients with benign prostatic "obstruction" (symptomatic BPH) Br J Urol 76 1995 325 336
29. H. Lepor Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia Urology 51 1998 892 900
30. M.K. Brawer, G. Adams, and H. Epstein Terazosin in the treatment of benign prostatic hyperplasia Arch Fam Med 2 1993 929 935
31. M. Andersen, C. Dahlstrand, and K. Høye Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia Eur Urol 38 2000 400 409
32. M.J. Barry, F.J. Fowler, M.P. O'Leary, R.C. Bruskewitz, H.L. Holtgrewe, W.K. Mebust The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557
33. S. Boyarsky, G. Jones, D.F. Paulson, and G.R. Prout A new look at bladder neck obstruction by the Food and Drug Administration: Guidelines for investigation of benign prostatic hypertrophy Trans Am Assoc Genitourin Surg 68 1976 29 36
34. Madsen PO, Iversen P. A point system for slecting operative candidates. In: Hinman Jr F, editor. Benign prostatic hypertrophy. New York: Springer-Verlag; 1983, p. 763-5.
35. J.L. Donovan, P. Abrams, T.J. Peters, H.E. Kay, J. Reynard, and C. Chapple The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire Br J Urol 77 1996 554 562
36. J.E. Ware Jr., and C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 30 1992 473 483
37. C.A. McHorney, J.E. Ware Jr., and A.E. Raczek The MOS 36-item Short-Form Health Survey (SF-36):II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care 31 1993 247 263
38. M.J. Barry, F.J. Fowler, M.P. O'Leary, R.C. Bruskewitz, H.L. Holtgrewe, and W.K. Mebust Measuring disease-specific health status in men with benign prostatic hyperplasia Med Care 33 1995 AS145 AS155
39. J.L. Donovan, H.E. Kay, T.J. Peters, P. Abrams, J. Coast, and A. Matos-Ferreira Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society-Benign Prostatic Hyperplasia Br J Urol 80 1997 712 721
40. B. Lukacs, D. Comet, J.C. Grange, and P. Thibault Construction and validation of a short form benign prostatic hypertrophy health-related quality-of-life questionnaire Br J Urol 80 1997 722 730
41. R.S. Epstein, P.A. Deverka, C.G. Chute, L. Panser, J.E. Oesterling, and M.M. Lieber Validation of a new quality of life questionnaire for benign prostatic hyperplasia J Clin Epidemiol 45 1992 1431 1445
42. T. Hald, J. Nordling, J.T. Andersen, T. Bilde, H.H. Meyhoff, and S. Walter A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia Scand J Urol Nephrol Suppl 138 1991 59 62
43. H.H. Meyhoff, T. Hald, J. Nordling, J.T. Andersen, T. Bilde, and S. Walter A new patient weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia Scand J Urol Nephrol 27 1993 493 499
44. R. Asplund, and H.E. Åberg Nocturnal micturition, sleep and well-being in women of ages 40-64 years Maturitas 24 1996 73 81
45. T. Kageyama, M. Kabuto, H. Nitta, Y. Kurokawa, K. Taira, and S. Suzuki Prevalence of nocturia among Japanese adults Psychiatry Clin Neurosci 54 2000 299 300
46. L. Abraham, A. Hareendran, I.W. Mills, M.L. Martin, P. Abrams, and M.J. Drake Development and validation of a quality of life measure for men with nocturia Urology 63 2004 481 486
47. D.J. Buysse, C.F. Reynolds, T.H. Monk, S.R. Berman, and D.J. Kupfer The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research Psychiatry Res 28 1989 193 213
48. K. Avery, H. Hashim, N. Gardener, P. Abrams, J. Donovan, and L. Abraham Development and psychometric evaluation of the ICIQ nocturia module: The ICIQ-N Neurourol Urodyn 23 2004 Abstract 595
49. J. Ware Jr., M. Kosinski, and S.D. Keller A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity Med Care 34 1996 220 233
50. N. Stanley The Physiology of sleep and the impact of ageing Eur Urol Suppl 3 6 2005 17 23
51. T. Åkerstedt, and P.M. Nilsson Sleep as a restitution: an introduction J Int Med 254 2003 6 12
52. B. Djavan, S. Milani, J. Davies, and J. Bolodeoku The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: preliminary results of a pilot study Eur Urol Suppl 4 2 2005 61 68
53. W.W. Tryon Issues of validity in actigraphic sleep assessment Sleep 27 2004 158 165
54. A. Vallieres, and C.M. Morin Actigraphy in the assessment of insomnia Sleep 26 2003 902 906
55. A. Sadeh, P.J. Hauri, D.F. Kripke, and P. Lavie The role of actigraphy in the evaluation of sleep disorders Sleep 18 1995 288 302
56. S. Ancoli-Israel, R. Cole, C. Alessi, M. Chambers, W. Moorcroft, and C.P. Pollak The role of actigraphy in the study of sleep and circadian rhythms Sleep 26 2003 342 392
57. C.A. Kushida, A. Chang, C. Gadkary, C. Guilleminault, O. Carrillo, and W.C. Dement Comparison of actigraphy, polysomnographic and subjective assessment of sleep parameters in sleep-disordered patients Sleep Med 2 2001 389 396
58. J.D. Edinger, M.K. Means, K.M. Stechuchak, and M.K. Olsen A pilot study of inexpensive sleep-assessment devices Behav Sleep Med 2 2004 41 49